<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02372058</url>
  </required_header>
  <id_info>
    <org_study_id>10002</org_study_id>
    <nct_id>NCT02372058</nct_id>
  </id_info>
  <brief_title>Transcutaneous Bilirubinometry in Neonates With Bilicare System</brief_title>
  <official_title>Transcutaneous Bilirubinometry in Neonates With Bilicare System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gerium Medical</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gerium Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to define the performance evaluation of BiliCare TcB
      device to the &quot;gold standard&quot; bilirubin tests.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neonatal hyperbilirubinemia or newborn jaundice impacts over 85% of all newborns [1].
      Regardless of the mechanism, excessive hyperbilirubinemia has been traditionally treated with
      phototherapy to minimize any probable risk of developing bilirubin-induced neurotoxicity.
      However, earlier and more recent data suggest that pre-discharge bilirubin screening for risk
      of significant hyperbilirubinemia, whether due to a rapid bilirubin production or an earlier
      age of onset, has impacted the guidelines for clinical use of phototherapy [1, 2]. In this
      study, we plan to test the performance of a novel transcutaneous device (BiliCareTM) first
      for screening for bilirubin levels at postnatal age of 6 to 48 hrs; and possibly also, to
      substitute the use of this measurement for total plasma/serum bilirubin (TB). This device
      applies a novel light transmission technology that has the potential to measure bilirubin as
      a point-of-care test in the subcutaneous tissue, and then uses an internal algorithm to
      calculate bilirubin levels in the skin. In this proposalstudy, we will to assess the clinical
      performance of the BiliCare by correlating measurements made by this device to
      near-concurrent measure of total plasma/serum bilirubin at normative ranges (mean, median,
      range and inter-quartile ranges ) for all term and late-preterm newborns (including those who
      are at-risk for jaundice and / or being administered with phototherapy) born to families of
      diverse race and ethnic backgrounds.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BiliCare TcB Result Compared to TSB Result</measure>
    <time_frame>30 minutes within taking the blood draw for TSB (either before or after the blood draw)</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>We Will Focus on Assessing the Clinical Performance of the BiliCare Device</condition>
  <arm_group>
    <arm_group_label>BiliCare</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Three non invasive measurements of TcB:
Two measurements with the BiliCare device and one measurement with a competitive FDA approved device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiliCare</intervention_name>
    <description>Three non invasive measurements of TcB:
Two measurements with the BiliCare device and one measurement with a competitive FDA approved device</description>
    <arm_group_label>BiliCare</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parental informed consent

          -  Male and female newborns with a GA â‰¥ 35 wks

          -  Enrollment at age &gt; 6 hrs until neonatal discharge.

          -  Pre-phototherapy

        Exclusion Criteria:

          -  Infants requiring respiratory assistance (such as mechanical ventilation)

          -  Severe or life-threatening congenital anomalies

          -  Hematomas at the point of measurement on both ears

          -  Neonates undergone blood transfusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Schutzman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Einstein Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Einstein Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2015</study_first_submitted>
  <study_first_submitted_qc>February 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2015</study_first_posted>
  <results_first_submitted>August 13, 2015</results_first_submitted>
  <results_first_submitted_qc>August 13, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 11, 2015</results_first_posted>
  <last_update_submitted>August 13, 2015</last_update_submitted>
  <last_update_submitted_qc>August 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Late Preterm and Term Newborns</title>
          <description>The study population will consist of term and late preterm newborns (infants &gt;=35 weeks gestational age)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="103"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="100"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Number of participants who completed the study</population>
      <group_list>
        <group group_id="B1">
          <title>Late Preterm and Term Newborns</title>
          <description>The study population will consist of term and late preterm newborns (infants &gt;=35 weeks gestational age)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Hours since birth</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.5" spread="19.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>BiliCare TcB Result Compared to TSB Result</title>
        <time_frame>30 minutes within taking the blood draw for TSB (either before or after the blood draw)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BiliCare TcB Average</title>
            <description>The study population will consist of term and late preterm newborns (infants &gt;=35 weeks gestational age) measured with one BiliCare TcB device without an infection control tip and with one BiliCare TcB device with an infection control tip.
This is the average of both devices</description>
          </group>
          <group group_id="O2">
            <title>JM103 TcB</title>
            <description>The study population will consist of term and late preterm newborns (infants &gt;=35 weeks gestational age) measured with the JM103 TcB device</description>
          </group>
          <group group_id="O3">
            <title>Total Serum Bilirubin (TSB)</title>
            <description>The study population will consist of term and late preterm newborns (infants &gt;=35 weeks gestational age) measured routinely for total serum bilirubin by diazo method.</description>
          </group>
        </group_list>
        <measure>
          <title>BiliCare TcB Result Compared to TSB Result</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="100"/>
                <count group_id="O3" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.46" spread="2.68"/>
                    <measurement group_id="O2" value="7.93" spread="3.48"/>
                    <measurement group_id="O3" value="7.83" spread="3.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Late Preterm and Term Newborns</title>
          <description>The study population will consist of term and late preterm newborns (infants &gt;=35 weeks gestational age)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. David L. Schutzman</name_or_title>
      <organization>Albert Einstein Medical Center located in Philadelphia, Pennsylvania, USA</organization>
      <phone>215-456-6698</phone>
      <email>schutzmand@einstein.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

